BPC-157 accelerates healing of Achilles tendon in rats

Journal of Applied Physiology·2011·Cerovecki T, Bojovic V, Brcic L, et al.·Journal of Applied Physiology

This preclinical study investigated BPC-157 in a rat model of Achilles tendon transection. Treated animals showed improved tendon healing, increased collagen organization, and earlier recovery of mechanical strength compared to controls. The authors proposed that BPC-157 may promote healing through growth factor upregulation.

Why this research is interesting

BPC-157 is widely discussed in peptide research communities, but the primary evidence consists largely of preclinical studies like this one. Understanding the actual evidence base helps distinguish what is known from what is assumed.

What the research says

In a rat Achilles tendon transection model, BPC-157 treatment was associated with faster tendon healing, improved collagen fiber organization, and earlier recovery of tensile strength compared to untreated controls.

What the evidence shows

This is an animal study in rats. No human clinical trials are available for BPC-157. The findings suggest a biological effect in this specific model but do not establish efficacy or safety in humans.

What remains uncertain

Translation from rat tendon models to human tendon healing is uncertain. No controlled human studies, pharmacokinetic data in humans, or safety evaluations in clinical settings have been published. The mechanism of action remains incompletely characterized.